EUVIMEDEUVIMED entdecken
Fallbericht

PULMONARY EMBOLISM WITH ANTIPHOSPHOLIPID SYNDROME: A CASE REPORT

Sidhi Laksono Purwowiyoto, Ferel M, Yeria R, Reynaldo Halomoan, Kurniawan

Sanus Medical Journal · 2021

DOI: 10.22236/sanus.v2i2.7256 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Sanus Medical Journal, 2021. Verfasst von Sidhi Laksono Purwowiyoto und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antiphospolypid sí­ndrome (APS) is a systemic autoimmune condition that is related to vascular thrombosis. Patients with APS are at risk for developing pulmonary embolism (PE) events. In this case, we present a 68 years old female with complaints of sudden onset of persistent shortness of breath for two days. No past medical history was identified. Physical and diagnostic examination revealed the presence of PE and antiphospolipid antibodies. Diagnosis of PE and APS were made. Patients then received initial anticoagulant using enoxaparin subcutaneously. Initial anticoagulants in patients with APS and PE should be administered. However, it is important to choose the right anticoagulant. DOAC is contraindicated due to the increased risk of thromboembolic events.

Zitieren

APA

Purwowiyoto, S. L., M, F., R, Y., Halomoan, R., & Kurniawan (2021). PULMONARY EMBOLISM WITH ANTIPHOSPHOLIPID SYNDROME: A CASE REPORT. Sanus Medical Journal. https://doi.org/10.22236/sanus.v2i2.7256

Vancouver

Purwowiyoto SL, M F, R Y, Halomoan R, Kurniawan. PULMONARY EMBOLISM WITH ANTIPHOSPHOLIPID SYNDROME: A CASE REPORT. Sanus Medical Journal. 2021. doi:10.22236/sanus.v2i2.7256

BibTeX
@article{Purwowiyoto2021,
  author = {Purwowiyoto, Sidhi Laksono and M, Ferel and R, Yeria and Halomoan, Reynaldo and Kurniawan},
  title = {PULMONARY EMBOLISM WITH ANTIPHOSPHOLIPID SYNDROME: A CASE REPORT},
  journal = {Sanus Medical Journal},
  year = {2021},
  doi = {10.22236/sanus.v2i2.7256}
}
Kostenlos starten →